发明名称 |
Dry powder drug delivery system |
摘要 |
A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation. |
申请公布号 |
US9393372(B2) |
申请公布日期 |
2016.07.19 |
申请号 |
US201313933845 |
申请日期 |
2013.07.02 |
申请人 |
MannKind Corporation |
发明人 |
Smutney Chad C.;Adamo Benoit;Polidoro John M.;Kinsey P. Spencer;Overfield Dennis;Sahi Carl R.;Billings Christine;Marino Mark T. |
分类号 |
A61K9/14;A61M13/00;A61M15/00 |
主分类号 |
A61K9/14 |
代理机构 |
K&L Gates LLP |
代理人 |
K&L Gates LLP ;Cullman Louis C.;Novak Brian J. |
主权项 |
1. An inhalation system, comprising:
a dry powder inhaler comprising: a mouthpiece and a container, wherein the container comprises a top and a bottom which are moveable relative to one another by a translational motion to create a first flow path, wherein 20% to 70% of total airflow through the inhaler enters and exits the container, and wherein the container includes a dry powder formulation comprising diketopiperazine particles; and a second flow path wherein 30-80% of total airflow through the inhaler by-passes the container; wherein the second flow path converges with the first flow path at a substantially perpendicular angle, and wherein after a single inhalation from the inhalation system, diketopiperazine in a subject's plasma has an AUC0-∞ greater than 2,300 ng*min/mL per mg of the diketopiperazine content in the dry powder formulation. |
地址 |
Valencia CA US |